Related Experiment Videos
Cholesterol embolisation: a lethal complication of vascular catheterisation
P A Gaines1, D C Cumberland, A Kennedy
1Department of Radiology, Northern General Hospital, Sheffield.
Lancet (London, England)
|January 23, 1988
Summary
Cholesterol embolisation syndrome can occur after vascular catheterisation, especially with aortic manipulation. Symptoms include leg pain and skin changes, potentially leading to confusion, renal failure, and death.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Nephrology
Background:
- Vascular catheterisation is a common medical procedure.
- Atherosclerosis and aortic disease are prevalent conditions.
- Complications of invasive vascular procedures require careful monitoring.
Observation:
- Five patients experienced cholesterol embolisation syndrome following vascular catheterisation.
- Difficult catheter manipulation in a diseased aorta was a frequent preceding factor.
- Patients presented with characteristic skin and limb symptoms despite palpable pulses.
Findings:
- Cholesterol embolisation syndrome presents with specific clinical signs.
- The condition is linked to aortic manipulation during catheterisation.
- Livedo reticularis and leg pain are key early indicators.
Implications:
- Early recognition of cholesterol embolisation syndrome is crucial for patient outcomes.
- This syndrome highlights the risks associated with complex aortic interventions.
- Further research into preventative strategies for cholesterol embolisation is warranted.